Michael A Martino
CIK 1238250 · CEO · last filed 2023-05-26
Michael A Martino is a CEO who has filed 19 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider bought $22.1K of AMPE on May 26, 2023. Across all open-market trades the lifetime net is −$485.3K, making them a net seller over the disclosed history. 5 SEC filings were submitted jointly with Ampio Pharmaceuticals, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OGXI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
11080 ROSELLE STREET
SAN DIEGO, CA 92121
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ampio Pharmaceuticals, Inc. (AMPE) Delisted | CEO | 3,844 | $0.18 | $704 | $22.1K | 4 | 2023-05-26 |
| AMBIT BIOSCIENCES CORP (AMBI) Delisted | Chief Executive Officer | — | $0.54 | — | $0 | 3 | 2014-11-12 |
| ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Director | 1,000 | — | — | -$507.4K | 10 | 2010-07-08 |
| ACHIEVE LIFE SCIENCES, INC. (SNUS) Delisted | President & CEO | — | — | — | $0 | 2 | 2008-03-20 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-26 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Buy (P) | +76,890 | $22.1K | EDGAR |
| 2022-01-03 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-24 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-25 | Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-12 | AMBIT BIOSCIENCES CORP (AMBI) Delisted | Disp (D) | — | $0 | EDGAR |
| 2014-01-10 | AMBIT BIOSCIENCES CORP (AMBI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-07-18 | AMBIT BIOSCIENCES CORP (AMBI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-07-08 | ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Mixed | — | -$14.8K | EDGAR |
| 2010-06-23 | ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Mixed | — | $14.1K | EDGAR |
| 2010-06-21 | ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Mixed | — | $34.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.